Cite this article
Volume | Year
European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.
Endometrial adenocarcinoma in young-aged women: a Turkish population study
T. Gungor1, N. Cetinkaya2,*, B. Ozdal2, H. Yalcin2, S. Erkaya3, H. I. Yakut4
1 Hitit University Medical Faculty, Department of Obstetrics and Gynecologic Oncology, Corum
2 Zekai Tahir Burak Women’s Health Education and Research Hospital, Department of Gynecologic Oncology, Ankara
3 Zekai Tahir Burak Women’s Health Education and Research Hospital, Department of Obstetrics and Gynecology, Ankara
4 Zekai Tahir Burak Women’s Health Education and Research Hospital, Department of Pediatrics, Ankara (Turkey)
Eur. J. Gynaecol. Oncol. 2015, 36(6), 667–671; https://doi.org/10.12892/ejgo2712.2015
Published: 10 December 2015
Purpose of investigation: The present study aims to investigate the incidence, clinicopathological features, and experience of treatment outcomes of patients with endometrial adenocarcinoma (EC) at ≤ 40 years of age in a gynecologic oncology reference center in Ankara, Turkey. Materials and Methods: This retrospective study included 577 patients with EC, diagnosed and treated between 2007 and 2013. Results: The incidence of EC ≤ 40 years of age was 5.1% (n: 30). The mean age at diagnosis was 35.5 (range: 27-40). Most of the patients with EC were overweight or obese. However, 23% had normal body mass index (BMI). Infertility was seen as a risk factor in 38.4%. The mean duration of postoperative follow-up was 38.3 months with rates of disease persistence and recurrence 14.2% and 28.5%, respectively. Conclusion: The disease is diagnosed usually in its early stage and has a good prognosis. Appropriately selected patients with fertility desire have the opportunity to conceive with conservative management.